Pharmacological inhibition of PCSK9 (proprotein convertase subtilisin/kexin type nove) is an established therapeutic option to treat hypercholesterolemia and plasma PCSK9 levels have been implicated in cardiovascular disease incidence. This biography of a living person needs additional citations for verification. Please help by adding reliable sources. Contentious material about livin... http://m-rcio-bittencourt-empres79000.bloggosite.com/10524586/tudo-sobre-marcio-bittencourt